Schedule 13G ownership disclosure

CHINOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 16961L106

Event date: 2020-10-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,028,937
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-037370
Form type
SC 13G
Filer
ATP Life Science Ventures, L.P.
CIK
CIK 1593440
Filed
Nov 16, 2020
Reporting period
Oct 05, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub